NL6504268A
(fr)
*
|
1965-04-03 |
1966-10-04 |
|
|
US3466325A
(en)
*
|
1965-04-30 |
1969-09-09 |
Haessle Ab |
1-(ortho-alkenyl phenoxy) - 2-hydroxy-3-isopropylaminopropanes and the salts thereof
|
US3959359A
(en)
*
|
1968-01-23 |
1976-05-25 |
Laboratoires Laroche Navarron |
Phenoxyalkylamines, process for their preparation and therapeutical composition containing same
|
US3534084A
(en)
*
|
1968-10-16 |
1970-10-13 |
Squibb & Sons Inc |
Adamantylamino-naphthyloxypropanols and related compounds
|
SE372762B
(fr)
*
|
1969-05-21 |
1975-01-13 |
Haessle Ab |
|
US3961072A
(en)
*
|
1969-12-17 |
1976-06-01 |
Pfizer Inc. |
Phenoxypropanolamine therapeutic agents
|
US3996284A
(en)
*
|
1971-03-23 |
1976-12-07 |
Wijbe Thomas Nauta |
Naphthyl and tetrahydronaphthyl di-ethers
|
BE790165A
(fr)
*
|
1971-12-14 |
1973-02-15 |
Parke Davis & Co |
Nouveaux aminoalcanols et procede pour les preparer
|
DE2354444A1
(de)
*
|
1973-10-31 |
1975-05-07 |
Merck Patent Gmbh |
Biphenylylaether und verfahren zu ihrer herstellung
|
US4051186A
(en)
*
|
1974-06-20 |
1977-09-27 |
The Regents Of The University Of California |
Amino-propranolol
|
US4379167A
(en)
*
|
1974-10-25 |
1983-04-05 |
A. H. Robins Company, Inc. |
1-Aryloxy-4-amino-2-butanols and the pharmaceutical use thereof
|
DE2505423A1
(de)
*
|
1975-02-08 |
1976-08-19 |
Merck Patent Gmbh |
Biphenylylaether und verfahren zu ihrer herstellung
|
US4071552A
(en)
*
|
1976-05-19 |
1978-01-31 |
Ayerst Mckenna And Harrison Ltd. |
Aryloxy aminobutanols, their preparation and use thereof
|
US4201866A
(en)
*
|
1977-01-17 |
1980-05-06 |
American Home Products Corporation |
O-Hemi-succinate of propranolol
|
US4463190A
(en)
*
|
1977-07-05 |
1984-07-31 |
A. H. Robins Company, Inc. |
1-Aryloxy-4-amino-2-butanols
|
DE2962112D1
(en)
*
|
1978-02-08 |
1982-03-25 |
Ici Plc |
Alkanolamine derivatives, process for their preparation and pharmaceutical compositions containing them
|
US4241177A
(en)
*
|
1978-08-28 |
1980-12-23 |
Syva Company |
Propanolol antigen conjugates and antibodies
|
US4585785A
(en)
*
|
1979-01-09 |
1986-04-29 |
A. H. Robins Company, Inc. |
Cis and trans-3-aryloxy-4-hydroxypyrrolidines used as anti-arrhythmics
|
RO71464A2
(fr)
*
|
1979-02-23 |
1981-05-15 |
Intreprinderea De Medicamente,Ro |
Procede pour fabriquer 1-(1-naphtoxy) 3-iso-propylamino-2-propanole
|
US4284648A
(en)
*
|
1979-08-03 |
1981-08-18 |
The University Of Kentucky Research Foundation |
Nasal administration of propranolol
|
DE3068678D1
(en)
*
|
1979-08-10 |
1984-08-30 |
Sandoz Ag |
3-aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them
|
US4376125A
(en)
*
|
1980-11-05 |
1983-03-08 |
University Of Virginia Alumni Patents Foundation |
Aminobenzlpropranolol and pharmaceutical preparation thereof
|
US4405642A
(en)
*
|
1980-11-28 |
1983-09-20 |
American Hospital Supply Corporation |
Method for treatment or prophylaxis of cardiac disorders
|
US4321398A
(en)
*
|
1981-05-07 |
1982-03-23 |
Mead Johnson & Company |
Thienyl and benzothienyl-tertiary butylaminophenoxypropanols
|
US4402974A
(en)
*
|
1981-06-23 |
1983-09-06 |
American Hospital Supply Corporation |
Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
|
FR2521136A1
(fr)
*
|
1982-02-05 |
1983-08-12 |
Synthelabo |
Derives de piperidine, leur preparation et leur application en therapeutique
|
IT1212552B
(it)
*
|
1982-10-20 |
1989-11-30 |
Italo Britannica L Manet Ti H |
Alcanolaminossi derivati di 3,4-diidro-2h-1.4-benzotiazin-3-one, loro procedimento di produzione e loro utilizzazione farmaceutica
|
US4517188A
(en)
*
|
1983-05-09 |
1985-05-14 |
Mead Johnson & Company |
1-Pyrimidinyloxy-3-hetaryl-alkylamino-2-propanols
|
NZ208337A
(en)
*
|
1983-06-10 |
1988-10-28 |
Bristol Myers Co |
2-(2-hydroxy-3-((2-(ar-hydroxy-1h-aminopropoxy-yl)ethyl benzonitriles and pharmaceutical compositions
|
DE3330005A1
(de)
*
|
1983-08-19 |
1985-02-28 |
Wolfgang Dr. Graz Lindner |
Weinsaeuremonoester von optisch aktiven alkanolaminen, verfahren zu ihrer herstellung und ihre verwendung
|
US4593039A
(en)
*
|
1984-04-02 |
1986-06-03 |
Merck & Co., Inc. |
1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
|
US4897355A
(en)
*
|
1985-01-07 |
1990-01-30 |
Syntex (U.S.A.) Inc. |
N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
US5545412A
(en)
*
|
1985-01-07 |
1996-08-13 |
Syntex (U.S.A.) Inc. |
N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor
|
JPS61210063A
(ja)
*
|
1985-03-14 |
1986-09-18 |
Mitsubishi Chem Ind Ltd |
アリ−ルスルホン類
|
US5095151A
(en)
*
|
1985-05-21 |
1992-03-10 |
American Home Products Corporation |
Preparation of propranolol hydrochloride macrocrystals
|
US4888354A
(en)
*
|
1987-12-21 |
1989-12-19 |
Theratech, Inc. |
Skin penetration enhancement using free base and acid addition salt combinations of active agents
|
US5013761A
(en)
*
|
1988-06-03 |
1991-05-07 |
Eli Lilly And Company |
Serotonin antagonists
|
US5387613A
(en)
*
|
1993-07-23 |
1995-02-07 |
Ribogene, Inc. |
Treatment of tachyarrhythmias of supraventricular origin
|
CA2134038C
(fr)
*
|
1994-06-16 |
1997-06-03 |
David Taiwai Wong |
Potentialisation des effets de medicaments
|
EP0714663A3
(fr)
|
1994-11-28 |
1997-01-15 |
Lilly Co Eli |
Potentialisation d'un médicament par un antagoniste du récepteur sérotonine 1A
|
ES2145977T3
(es)
*
|
1995-08-16 |
2000-07-16 |
Lilly Co Eli |
Potenciacion de la respuesta de la serotonina.
|
US5776985A
(en)
*
|
1995-11-16 |
1998-07-07 |
The George Washington University |
Fluorinated propranolol and related methods
|
US5967613A
(en)
*
|
1997-08-11 |
1999-10-19 |
Piccard Corporation |
Wheelchair support and attachment system
|
GB0023467D0
(en)
*
|
2000-09-25 |
2000-11-08 |
Btg Int Ltd |
Amine compounds
|
US7022342B2
(en)
|
2002-03-28 |
2006-04-04 |
Andrx Corporation, Inc. |
Controlled release oral dosage form of beta-adrenergic blocking agents
|
RS20050106A
(en)
|
2002-08-19 |
2007-11-15 |
Pfizer Products Inc., |
Combination therapy for hyperproliferative diseases
|
US20050037063A1
(en)
*
|
2003-07-21 |
2005-02-17 |
Bolton Anthony E. |
Combined therapies
|
US20060063803A1
(en)
*
|
2004-09-23 |
2006-03-23 |
Pfizer Inc |
4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
|
US20060182806A1
(en)
*
|
2004-11-08 |
2006-08-17 |
Mintong Guo |
Extended-release propranolol composition
|
AP2764A
(en)
*
|
2005-01-31 |
2013-09-30 |
Mylan Lab Inc |
Hydroxylated nebivolol metabolites
|
GT200600381A
(es)
|
2005-08-25 |
2007-03-28 |
|
Compuestos organicos
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
US8404896B2
(en)
|
2006-12-01 |
2013-03-26 |
Bristol-Myers Squibb Company |
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
|
US8686051B2
(en)
*
|
2007-01-29 |
2014-04-01 |
Vlife Sciences Technologies Pvt. Ltd. |
Pharmaceutical composition for treatment of diabetic complications
|
WO2008112287A1
(fr)
|
2007-03-12 |
2008-09-18 |
Nektar Therapeutics |
Conjugués d'oligomère bêtabloquant
|
AU2014255381A1
(en)
|
2013-04-17 |
2015-10-08 |
Pfizer Inc. |
N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
|
EP2959904A1
(fr)
|
2014-06-27 |
2015-12-30 |
Institut De Recerca Contra La Leucemia Josep Carreras |
Procédés pour traiter, diagnostiquer et pronostiquer une tumeur maligne hématologique
|
WO2016055901A1
(fr)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Composés d'amide substitué
|
WO2018161039A1
(fr)
|
2017-03-03 |
2018-09-07 |
Synovo Gmbh |
Nouveaux composés anti-infectieux et anti-inflammatoires
|
WO2018187606A1
(fr)
|
2017-04-07 |
2018-10-11 |
Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center |
PROCÉDÉS ET COMPOSITIONS POUR MODULER LES INTERACTIONS β-AMYLOÏDE/α7-NACHR
|
MX2021008533A
(es)
|
2019-01-18 |
2021-08-19 |
Astrazeneca Ab |
Inhibidores de la pcsk9 y metodos de uso de los mismos.
|